Reneo Pharmaceuticals, Inc. - Class A Common Stock (NQ:RPHM)

1.820 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Reneo Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

October 04, 2024

From Reneo Pharmaceuticals, Inc.; OnKure Therapeutics, Inc.

Via GlobeNewswire

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

October 02, 2024

From Reneo Pharmaceuticals, Inc.

Via GlobeNewswire

Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying ↗

September 17, 2024

Via Benzinga

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

September 03, 2024

From Halper Sadeh LLC

Via Business Wire

Reneo Pharmaceuticals: Q4 Earnings Insights ↗

March 28, 2024

Via Benzinga

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

August 29, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Citizens And 2 Other Penny Stocks Insiders Are Buying ↗

August 15, 2024

Via Benzinga

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024 ↗

August 13, 2024

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 13, 2024

From Reneo Pharmaceuticals, Inc.

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SBOW, AGR, RPHM on Behalf of Shareholders

June 25, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM)

June 25, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders

June 21, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBOW, PRFT, RPHM on Behalf of Shareholders

June 18, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM), Perficient, Inc. (Nasdaq - PRFT)

June 18, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BATL, DRQ, RPHM, PRFT on Behalf of Shareholders

June 14, 2024

From Halper Sadeh LLC

Via GlobeNewswire

June 07, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE – AGR), SilverBow Resources, Inc. (NYSE – SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), Perficient, Inc. (Nasdaq – PRFT)

May 29, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

ALERT: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, UNIT; Shareholders are Encouraged to Contact the Firm

May 29, 2024

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 28, 2024

Via Benzinga

May 20, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 17, 2024

Via Benzinga

Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying ↗

May 17, 2024

Via Benzinga

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

May 14, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

What's Going On With Reneo Pharmaceuticals Stock Today? ↗

May 13, 2024

Reneo and Onkure announced Monday that they have entered into a definitive merger agreement to combine the two companies in an all-stock transaction.

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), ALLETE, Inc. (NYSE – ALE), Perficient, Inc. (Nasdaq – PRFT), Hibbett, Inc. (Nasdaq – HIBB)

May 13, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

May 13, 2024

From Halper Sadeh LLC

Via Business Wire

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

May 13, 2024

From Reneo Pharmaceuticals, Inc.; OnKure, Inc

Via GlobeNewswire

RPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024 ↗

May 07, 2024

RPHM stock results show that Reneo Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

May 07, 2024

From Reneo Pharmaceuticals, Inc.

Via GlobeNewswire

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023 ↗

March 28, 2024

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.